21st Sep 2018 07:01
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014
Westminster Group Plc
('Westminster', the 'Group' or the 'Company')
Appointment of Chief Financial Officer
Westminster Group Plc (AIM: WSG), a leading supplier of managed services and technology based security solutions, announces the appointment of Mark L W Hughes as Chief Financial Officer from 1 November 2018. Martin Boden, the current Chief Financial Officer, will be leaving the Company on 31 October 2018 to pursue new opportunities.
Mark Leonard William Hughes BSc MBA FCA, aged 63, is an experienced Group Chief Financial Officer with over 30 years' experience of leading groups, divisions and companies sized from pre-revenue to £600m turnover, including those listed on both the main market and AIM including CFO of Hall Engineering (Full) Royal Doulton (Full), Axon (Full) and Mediwatch (AIM).
Mark currently holds 70,000 ordinary shares in the Company, representing 0.05 per cent. of the issued share capital of the Company.
Mark will be joining the Risk Committee.
Commenting on Mark's appointment, Westminster's Chairman, Sir Tony Baldry, said:
"Mark's wide-ranging international experience, particularly in emerging markets together with his considerable experience in capital markets and in M&A work, with close to 40 M&A transactions completed, and as CFO of listed, venture capital, private and private equity owned companies, will be a great asset in assisting the Company achieve its growth potential.
"Mark has helped grow shareholder value in groups of similar size to ours. He also has worked in both Sierra Leone and the Middle East so brings significant experience in those geographical areas. We believe that his track record of growing groups both organically and through strategic acquisitions is the profile we need to take us to the next level
"I would like to express my thanks to Martin Boden for his support during his time with the business and we wish him well for the future."
The following details in relation to the appointment of Mr Hughes are disclosed in accordance with Schedule 2(g) of the AIM Rules:
Current directorships | Past directorships held within the last five years |
|
|
Twenty One Productions Limited Cell Therapy Limited
MLWH Limited Cell Therapy Tendoncel Limited
G&H (Warwick) Limited Cell Therapy Skincel Limited
Cell Therapy Oncology Limited
Cell Therapy Diabetes Limited
Mediwatch Genesis Limited
Medi-watch UK Limited
Mediwatch Biomedical Limited
Mediwatch Diagnostic Clinics Limited
Mediwatch PLC (now Mediwatch Limited)
Mediwatch Pathology Limited
Innovo Finance Limited
For further information, please contact:
Westminster Group Plc | Media enquiries via Walbrook PR |
Rt. Hon. Sir Tony Baldry - Chairman |
|
Peter Fowler - Chief Executive Officer |
|
Martin Boden - Chief Financial Officer |
|
|
|
S. P. Angel Corporate Finance LLP (NOMAD & Broker) |
|
Stuart Gledhill | 020 3470 0470 |
Lindsay Mair |
|
Caroline Rowe |
|
|
|
Walbrook (Investor Relations) |
|
Tom Cooper | 020 7933 8780 |
Paul Vann | 0797 122 1972 |
|
Notes:
Westminster Group plc is a specialist security and services group operating worldwide through an international network of agents and offices in over 50 countries.
Westminster's principal activity is the design, supply and on-going support of advanced technology security solutions, encompassing a wide range of surveillance, detection, tracking and interception technologies and the provision of long-term managed services contracts such as the management and running of complete security services and solutions in airports, ports and other such facilities together with the provision of manpower, consultancy and training services. The majority of its customer base, by value, comprises governments and government agencies, non-governmental organisations (NGO's) and blue chip commercial organisations.
Related Shares:
Westminster Group